We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Walgreens Boots Alliance Inc (WBA) USD0.01

Sell:$16.68 Buy:$16.69 Change: $1.22 (6.82%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Change: $1.22 (6.82%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
Change: $1.22 (6.82%)
Market closed |  Prices as at close on 21 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

Contact details

108 Wilmot Rd
United States
+1 (847) 3152500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$15.37 billion
Shares in issue:
862.71 million
Drug Retail
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Stefano Pessina
    Executive Chairman of the Board
  • Timothy Wentworth
    Chief Executive Officer, Director
  • Manmohan Mahajan
    Global Chief Financial Officer, Executive Vice President
  • Elizabeth Burger
    Chief Human Resource Officer, Executive Vice President
  • Neal Sample
    Executive Vice President, Chief Information Officer
  • Kevin Ban
    Executive Vice President, Chief Medical Officer
  • Mary Langowski
    Executive Vice President, President, U.S. Healthcare
  • Lanesha Minnix
    Executive Vice President, Global Chief Legal Officer
  • Todd Heckman
    Senior Vice President, Chief Accounting Officer, Global Controller
  • Tracey Brown
    Senior Vice President and President, Retail Products and Chief Customer Officer, Walgreen Co.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.